DEVELOPMENT OF HUMAN RECOMBINANT DECORIN CORE PROTEIN AS AN ANTI-SCARRING THERAPEUTIC FOR DYSTROPHIC EPIDERMOLYSIS BULLOSA
$2,991,032FY2019Defense Health AgencyDOD
Phoenicis Therapeutics Inc
Investigators
View source on USAspending →DEVELOPMENT OF HUMAN RECOMBINANT DECORIN CORE PROTEIN AS AN ANTI-SCARRING THERAPEUTIC FOR DYSTROPHIC EPIDERMOLYSIS BULLOSA · GrantIndex